Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Page Not Found
Cart summary

You have no items in your shopping cart.

ERK1/2 inhibitor 3

SKU: orb1983000

Description

ERK1/2 Inhibitor 3 is a potent and selective small molecule targeting the MAPK/ERK pathway. It is widely used in cancer and inflammation research, demonstrating utility in both in vitro cellular assays and in vivo disease models to study proliferation and signal transduction.

Research Area

Pharmacology & Drug Discovery; Cell Biology, Signal Transduction

Images & Validation

Key Properties

CAS Number2737294-99-2
MW620.09
FormulaC28H31ClFN5O6S
SMILESCOc1cc(F)cc(c1)[C@@H](CO)NC(=O)[C@H](C)N1Cc2ccc(cc2S1(=O)=O)-c1nc(NC2CCOCC2)ncc1Cl
TargetOthers

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Trametinib DMSO solvate [orb1226854]

    >98% (HPLC)

    1187431-43-1

    693.5283

    C28H29FIN5O5S

    50 mg, 100 mg, 200 mg, 500 mg, 1 g, 10 mg, 25 mg
  • ERK1/2 inhibitor 11 [orb2802230]

    333.41

    C15H19N5O2S

    50 mg, 10 mg
  • PDGFRA/CAIX/XII-IN-1 [orb3173017]

    507.56

    C25H25N5O5S

    5 mg, 25 mg, 10 mg, 1 mg
  • SHY-867 [orb3173624]

    2446484-96-2

    485.61

    C26H27N7OS

    50 mg, 10 mg
  • Theaflavin 3,3'-digallate [orb1301797]

    98.71% (May vary between batches)

    30462-35-2

    868.7

    C43H32O20

    5 mg, 10 mg, 1 mg, 25 mg, 50 mg, 100 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information